2023 annual financial data
Telomir Pharmaceuticals 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -3,942,048 USD and net income was -13,071,864 USD.
Operating cash flow was -3,859,796 USD.
Get free Telomir Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,942,048 USD
- Net income
- -13,071,864 USD
- Operating cash flow
- -3,859,796 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Telomir Pharmaceuticals financial years